ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1183

Proton Pump Inhibitor (PPI) for the Treatment of Metabolic Alkalosis due to Gastric Losses

Session Information

Category: Fluid, Electrolyte, and Acid-Base Disorders

  • 902 Fluid, Electrolyte, and Acid-Base Disorders: Clinical

Authors

  • Rosen, Raphael Judah, Columbia University Irving Medical Center, New York, New York, United States
  • Han, Heedeok, Columbia University Irving Medical Center, New York, New York, United States
  • Prakash-Polet, Sindhuri, Columbia University Irving Medical Center, New York, New York, United States
  • Peleg, Yonatan A., Columbia University Irving Medical Center, New York, New York, United States
Introduction

Gastric losses of hydrochloric acid can result in severe metabolic alkalosis (met alk). We describe two cases where patients with significant losses of gastric secretions presented with severe met alk and AKI. In both cases, PPI therapy was used to reduce the volume of the gastric secretions with excellent effect.

Case Description

Patient 1:
A 44 year-old woman with Gardner Syndrome with near-total enterectomy and colectomy on total parenteral nutrition with a venting gastric tube (G-tube), presented with met alk (HCO3 50 meq/L) and AKI (Scr 4 mg/dL from baseline 1.3 mg/dL). Met alk persisted despite normal saline (NS) administration and gastric tube losses ranged from 4-8 liters per day. Twice daily intravenous PPI was started with immediate decrease of gastric losses and normalization in HCO3. This patient was admitted one year later (off PPI therapy) with a similar derangements and resuming PPI therapy caused similar improvement.

Patient 2:
A 59 year-old man with gastric outlet obstruction and venting G-tube presented with met alk (HCO3 47 meq/L) and acute kidney injury (SCr 4.5 mg/dL from 1.3 mg/dL). Met alk persisted despite NS administration and his gastric tube losses ranged from 4-11 liters per day. Daily intravenous PPI was started with decrease of gastric losses and normalization of HCO3. This patient presented again to the hospital one month later with normal HCO3, on PPI therapy.

Both patients’ bicarbonate and gastric fluid output trend relative to PPI therapy is detailed in figure 1.

Discussion

There are few reported cases of PPI therapy for metabolic alkalosis due to gastric losses. Generally, met alk that occurs due to gastric losses is readily rectified by increased renal bicarbonate excretion, but this compensatory mechanism is limited in the setting of AKI. We report two cases in which PPI therapy successfully decreased the quantity of gastric fluid losses and rapidly improved metabolic alkalosis.